XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | nl | no | nz | pt | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US, Authority Hl7

16,400 resources

By Version

R2: 0
R2B: 0
R3: 524
R4: 15,438
R4B: 0
R5: 438
R6: 0

Start Prev Rows 9800 - 10000 Next

Package	Version	Identity	Name/Title	Status	Date
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.40	Unemployment Diagnoses ICD10CM	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.41	Unemployment Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.42	Unemployment Diagnoses	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.43	Housing Instability Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.46	Inadequate Housing Diagnoses SNOMED CT	active	2023-07
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.47	Inadequate Housing Diagnoses ICD10CM	active	2023-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.48	Inadequate Housing Diagnoses	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.49	Inadequate Housing Goals SNOMED CT	active	2023-07
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.5	Social Determinants of Health General Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.51	Inadequate Housing Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.54	Less Than High School Education Goals SNOMED CT	active	2024-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.58	Unemployment Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.6	Food Insecurity Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.61	Elder Abuse Diagnoses ICD10CM	active	2023-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.62	Elder Abuse Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.63	Elder Abuse Diagnoses	active	2022-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.64	Elder Abuse Goals SNOMED CT	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.66	Elder Abuse Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.69	Unemployment Goals SNOMED CT	active	2024-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.71	Social Determinants of Health Goals	active	2024-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.72	Stress Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.73	Stress Interventions SNOMED CT	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.74	Stress Diagnoses ICD10CM	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.75	Stress Diagnoses	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.76	Veteran Status Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.77	Veteran Status Diagnoses ICD10CM	active	2023-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.78	Veteran Status Diagnoses	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.79	Social Connection Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.8	Social Determinants of Health General Interventions CPT	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.80	Social Connection Diagnoses ICD10CM	active	2023-07
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.81	Social Connection Diagnoses	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.82	Intimate Partner Violence Diagnoses SNOMED CT	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.83	Intimate Partner Violence Diagnoses ICD10CM	active	2024-07
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.84	Intimate Partner Violence Diagnoses	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.85	Stress Goals SNOMED CT	active	2023-07
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.88	Social Connection Goals SNOMED CT	active	2024-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.9	Food Insecurity Interventions HCPCS	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.93	Social Connection Interventions SNOMED CT	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.96	Intimate Partner Violence Interventions SNOMED CT	active	2024-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1247.99	Intimate Partner Violence Goals SNOMED CT	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.119	Opioid Antagonist	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.12	High Risk Diagnosis for AKI	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.120	Opioids	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.124	Immune Modulators	active	2023-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.130	Suicide Attempt	active	2023-04
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.134	Central Nervous System Depressants	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.138	COVID19	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.139	COVID 19	active	2022-04
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.14	Hemolytic Uremic Syndrome (HUS)	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.140	COVID 19	active	2022-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.162	Obesity	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.163	Antidepressants	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.164	Antihypertensives	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.165	Delirium	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.166	Dementia	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.167	Psychosis	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.168	Delirium or Dementia and Other Psychoses	active	2022-10
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.169	Depression	active	2022-10
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.170	Diuretics	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.171	Epilepsy	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.172	Neurologic Movement Disorders	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.173	Neurologic Disorders, Other	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.174	Neurologic Movement and Related Disorders	active	2022-10
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.175	Peripheral Neuropathy	active	2022-10
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.176	Stroke	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.177	Abnormal Weight Loss and Malnutrition	active	2022-10
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.181	Tracheostomy Procedures	active	2022-07
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.187	Routes of Administration for Opioid Antagonists	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.19	High Risk Procedures for AKI	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.197	Hospital Based Dialysis Services	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.198	Hospital Based Dialysis Services	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.199	Hospital Based Dialysis Services	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.200	Nephrectomy	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.201	Thrombotic Thrombocytopenic Purpura	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.204	VTE Prophylaxis	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.206	General and Neuraxial Anesthesia	active	2023-04
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.207	General and Neuraxial Anesthesia	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.208	General and Neuraxial Anesthesia	active	2023-04
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.209	Non Invasive Oxygen Therapy by Nasal Cannula or Mask	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.21	Creatinine Mass Per Volume	active	2022-04
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.210	Continuous and Bilevel Positive Airway Pressure	active	2023-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.211	Continuous and Bilevel Positive Airway Pressure	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.213	Non Invasive Oxygen Therapy	active	2023-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.214	Non Invasive Oxygen Therapy Devices	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.216	Procedural Hospital Locations	active	2023-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.217	ASA physical status class	active	2023-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.218	Blood urea nitrogen lab test	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.219	Hemoglobin lab test	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.22	Anticoagulants for All Indications	active	2022-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.220	Smoking status	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.221	Albumin lab test	active	2023-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.222	Leukocyte count lab test	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.223	Bilirubin lab test	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.224	Aspartate transaminase lab test	active	2023-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.226	Cardiac Arrest	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.230	PO Antibacterials	active	2023-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.231	Injectable Antifungals	active	2023-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.24	Malignant Bone Disease	active	2022-10
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.242	Heart and Lung Transplants	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.243	Heart and Lung Transplants	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.245	Lung Resections and Excisions	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.246	Lung Resections and Excisions	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.247	Chest Wall Procedures	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.248	Chest Wall Procedures	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.249	Maxillary Procedures	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.250	Maxillary Procedures	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.251	Head, Neck, and Thoracic Surgeries with High Risk Airway Compromise	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.252	Anesthesia Requiring Monitored Care	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.253	Anesthesia Requiring Monitored Care	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.255	Anesthesia Requiring Monitored Care	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.256	Osteoporosis	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.260	Rivaroxaban Anticoagulant	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.262	Fondaparinux Anticoagulant	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.263	Dalteparin Anticoagulant	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.264	Heparin	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.268	Enoxaparin Anticoagulant	active	2024-06
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.271	Undetectable Lab Result Value	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.272	Undetectable Lab Result Value	active	2024-10
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.274	Dietary Recommendations	active	2025-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.275	Bariatric Procedures	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.276	Telemedicine Services	active	2025-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.277	Prostate Cancer Treatment	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.28	Traumatic Avulsion of Kidney	active	2022-04
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.29	Rapidly Progressive Nephritic Syndrome	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.301	LDL Cholesterol	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.33	Obstetrics and VTE Obstetrics	active	2022-04
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.34	Glucose Lab Test Mass Per Volume	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.349	Tuberculosis for Urology Care	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.350	Tuberculosis for Urology Care	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.351	Tuberculosis for Urology Care	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.352	Androgen Deprivation Therapy for Urology Care	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.353	Bacillus Calmette Guerin for Urology Care	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.354	Bladder Cancer for Urology Care	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.355	Chemotherapy Agents for Advanced Cancer	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.356	Cystectomy for Urology Care	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.357	Cystectomy for Urology Care	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.358	Cystectomy for Urology Care	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.359	DEXA Bone Density for Urology Care	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.360	Hospital Services for Urology Care	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.361	Immunocompromised Conditions	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.362	Immunocompromised Conditions	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.363	Immunocompromised Conditions	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.364	Immunosuppressive Drugs for Urology Care	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.365	Mixed Histology Urothelial Cell Carcinoma for Urology Care	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.366	Morbid Obesity	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.367	Morbid Obesity	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.368	Morbid Obesity	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.369	Unavailability of Bacillus Calmette Guerin for Urology Care	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.370	Urinary Retention	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.371	Urinary Retention	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.372	Urinary Retention	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.374	Face to Face Interaction	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.375	Face to Face Interaction	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.376	HIV Viral Load Tests	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.377	HIV Viral Load Tests	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.389	Syphilis Tests	active	2025-04
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.4	Nephrectomy	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1248.8	Large Body Surface Area (BSA) Burns	active	2022-04
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1250.2	Psychological Neuropsychological or Neurobehavioral Testing	active	2023-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1250.3	Psychological or Neuropsychological Testing	active	2023-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1251.10	Tricuspid Valve Regurgitation	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1251.2	Valvular Heart Disease	active	2022-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1258.1	Gonorrhea Screening	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1258.2	Abnormal Weight Loss	active	2024-10
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1259.2	Prescribable brand and generic non insulin drugs for hyperglycemia in Type 2 Diabetes	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1259.3	Prescribable brand and generic insulins and analogues	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1259.4	eGFR Using 2021 Race Free Formulas	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1259.5	Fructosamine in Serum or Plasma	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1259.6	Glucose tests in venous blood, capillary blood, serum/plasma for Diabetes	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1259.7	Creatinine in serum/plasma	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1259.9	IgE Agonists, prescribable	active	2023-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.10	Estrogen Receptor Testing for Orserdu	active	2023-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.100	MMR Proficient	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.101	Systemic Cancer Directed Therapy	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.102	Face To Face Interaction	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.104	Erdafitinib	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.107	Chemotherapy Encounter	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.108	Urothelial Cancers ICD9	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.109	Urothelial Cancer ICD10	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.110	Urothelial Cancers	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.111	Prior Therapies for Erdafitinib	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.112	Urothelial Cancer Histologies	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.113	Malignant Tumor Behavior	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.114	Localized Bladder Cancer Stage SNOMED	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.116	Localized Bladder Cancer Staging	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.117	Advanced Bladder Cancer Stage	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.118	Localized Bladder Cancer T Stage	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.119	Localized Bladder Cancer T Stage	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.120	Localized Bladder Cancer N Stage	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.121	Localized Bladder Cancer M Stage	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.122	Advanced Bladder Cancer M Stage	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.124	Locoregional Urothelial Cancer ICD9	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.125	Locoregional Urothelial Cancer ICD10	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.126	Locoregional Urothelial Cancer SNOMED	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.127	Locoregional Urothelial Cancer	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.128	FGFR3 Gene	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.129	FGFR3 Gene Interpretation Positive SNOMED	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.130	FGFR3 Gene Interpretation Positive LOINC	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.131	FGFR3 Gene Interpretation Positive NCI	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1260.133	FGFR3 Gene Interpretation Positive	active	2024-02